The COVID-19 pandemic has brought fundamental changes to the practice of medicine. As a more robust understanding of SARS-CoV-2 is elucidated, practices will require greater flexibility in order to adapt. Antiseptics, such as povidone-iodine (PVP-I), are now routinely employed and will play a greater role in the future of healthcare. Due to its ability to protect both patients and healthcare providers alike, PVP-I utilization, in the form of oral and nasal solutions, should be considered as an additional and expansive step in the standard precautions algorithm.
COVID-19, SARS-CoV-2, antiseptics, povidone-iodine, decontamination, antiviral
Access all of the content
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!